Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

Levodopa use in parkinsonian patients is associated with reduced vascular risk factors. In causal terms this finding might be attributed to the inhibitory action of levodopa-derived dopamine on the sympathetic nervous system.